| Affymax, Takeda confirm US registration strategy for peginesatide - pharmabiz.com |
|
|
pharmabiz.com "Our plan is to pursue approval of peginesatide for the treatment of anaemia in CRF patients on dialysis," said Arlene M. Morris, chief executive officer of |